EMA’s CHMP Recommends Seven Medicines for Approval

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended seven new products for European Commission approval, including one biosimilar and two orphan medicines, one being an advanced cell therapy.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor